Skip to main content

EDITORIAL article

Front. Med., 28 April 2023
Sec. Gastroenterology
This article is part of the Research Topic Reviews in Gastroenterology View all 10 articles

Editorial: Reviews in gastroenterology

\r\nTian Lan,&#x;Tian Lan1,2Brooke R. Druliner&#x;Brooke R. Druliner3Enis Kostallari
Enis Kostallari3*Huan Tong,
Huan Tong1,2*
  • 1Laboratory of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China
  • 2Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China
  • 3Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States

Editorial on the Research Topic
Reviews in gastroenterology

Introduction

Gastroenterology is a rapidly evolving discipline which covers diseases of the digestive tract (esophagus, stomach, and intestine) and digestive glands (liver, biliary tree, and pancreas). This Research Topic presents eight reviews which focus on the following specific conditions and diseases: gastroesophageal reflux disease, implications following cholecystectomy, locally advanced right colon cancer, appendiceal cancer, enteral nutrition, lumen-apposing metal stent, non-alcoholic fatty liver disease, and acute-on-chronic liver failure. Each of these complications, conditions and diseases account for an overwhelming disease burden in the fields of gastroenterology and hepatology.

Summary of the reviews

The standard treatments for gastroesophageal reflux disease (GERD) are lifestyle adjustment and proton pump inhibitors. The agonist of the gamma-aminobutyric acid receptor, baclofen reduces reflux by inhibiting lower esophageal sphincter relaxation, and is used as an alternative management for GERD (1). However, the efficacy and side effects of baclofen in GERD treatment still need investigations. Arabpour et al. systemically reviewed 26 clinical trials and highlighted that baclofen benefited four populations with GERD as below: adults, children, patients with gastroesophageal reflux-induced chronic cough, and hiatal hernia patients. Baclofen ameliorates reflux symptoms, as well as improves pH-monitoring and manometry results. It should be noted that most of the published clinical studies on baclofen treatment in GERD had small sample sizes, and approximately one third of them were not randomized clinical trials. Although baclofen seems to be a promising medication and diversifies the treatment of GERD, the use of baclofen in the treatment of GERD needs further investigation.

Cholecystectomy can disturb bile flow and bile acid circulation, thus dysregulating gut microbiota (2). Growing evidence has linked these changes after cholecystectomy to the development of colorectal cancer (CRC) (3, 4). Jiang et al. discussed how cholecystectomy results in altered bile acid homeostasis and gut microbiota. In addition, they highlight the mechanisms involved in these changes, which pose a higher risk of CRC compared to non-cholecystectomized patients. The authors also summarized the potential tumorigenic effect of secondary bile acids on CRC. The potential of bile acid treatment for CRC was also discussed. As there are a considerable number of patients receiving cholecystectomy worldwide, it alerts that these patients have a higher risk for CRC, and it is meaningful to enhance CRC screening in these populations.

Locally advanced right colon cancer (LARCC) invades neighboring organs such as the pancreas and the duodenum, which challenges surgical interventions (5). En bloc resection is considered a suitable surgical method for this situation but strong evidence from clinical trials is lacking (6). To identify the effect of en bloc resection in LARCC cases with neighboring organ invasion, the data of 117 patients showed that en bloc resection plus right hemicolectomy was superior to pancreaticoduodenectomy with respect to survival of LARCC (Ri et al.). Although more data are needed to validate this conclusion, en bloc resection plus right hemicolectomy might be a better surgical procedure for LARCC.

Appendiceal cancer is a rare gastrointestinal tumor with limited knowledge on its risk stratification, which hinders treatment strategies for this disease. To this end, Liu et al. collected and analyzed the clinical data from a cohort with a large number of patients with primary appendiceal cancer from the Surveillance, Epidemiology, and End Results database. Age, pathological stage, surgery, number of lymph nodes removed, T stage, N stage, M stage, and CEA are the independent prognosis factors for appendiceal cancer. A monogram survival prediction model was established and validated to predict 1, 3, and 5-year overall survival for patients with appendiceal cancer and stratify the risk to give the individualized treatment.

Enteral nutrition (EN) consists of the delivery of nutrients via tubes and is suggested as the first-line treatment to induce remission in pediatric inflammatory bowel disease (IBD) (7). However, the application of specific EN, such as exclusive EN, has not reached a consensus. Luo et al. reviewed 12 questionnaire survey studies regarding exclusive EN application in pediatric IBD, and summarized current opinions on EN methods, including treatment course, formula, and food reintroduction, which might help to standardize the use of EN in children IBD.

The lumen-apposing metal stent (LAMS) is a large-channel metal stent used in endoscopic ultrasonic-guided intervention and has been applied recently for pancreatic fluid collection drainage (8). However, this method has suffered from several drawbacks, such as complicated and difficult procedures. Yi et al. introduced a recently developed endoscopic approach combining LAMS and electro-cautery cyctotome, namely electro-cautery LAMS (EC-LAMS). EC-LAMS shows several advantages compared to conventional LAMS and double pigtail plastic stents, including easy deployment, lower cost, shorter processing time, broader indications, and lower risk of complications such as bleeding. In general, EC-LAMS seems to be a novel and promising method for stent placing.

Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease with increasing disease burden (9, 10). Grip strength (GS) is an index of muscle strength and is associated with metabolic function (11). As NAFLD patients are often accompanied by metabolic disorders, GS might be considered as an indicator of NAFLD. Han et al. systemically reviewed 10 cross-section studies to reveal the relationship between GS and NAFLD. They demonstrated that people with low GS have higher risk of NAFLD, while NAFLD patients are associated to lower GS than healthy population. However, these cross-section studies were only conducted in China and Korea, and it is still unclear whether these conclusions can be applied in other populations.

Acute-on-chronic liver failure (ACLF) is caused by acute decompensation based on chronic liver diseases (12). Laboratory studies are trying to clarify the pathogenesis of ACLF and discover potential therapeutic targets. However, one of the major obstacles is the lack of suitable ACLF animal models. To this end, Zhai et al. compared the characteristics of current ACLF mouse models. Moreover, they established an ACLF mouse model by sequential injection of carbon tetrachloride (CCl4) for 8 weeks, followed by a double dosage of CCl4 for 72 hours, and Klebsiella pneumoniae administration. This model recapitulates the usual clinical course of human ACLF and represents a potential animal model for future ACLF studies.

Conclusion

The reviews of this special issue summarize the recent advances in the field of gastroenterology and hepatology. These reviews encompass a wide range of diseases spanning the gastrointestinal tract and the liver. We are optimistic that the knowledge gaps identified by these reviews are the first step toward delivering better care for patients.

Author contributions

All authors drafted the manuscript. EK and HT revised the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This manuscript was supported by the Pinnacle Research Award from the American Association from the Study of Liver Diseases and Gilead Liver Scholar Award to EK, KL2 Scholar Career Development Award (KL2 TR002379), National Center for Advancing Translational Science to BD, the Corporation Project of Sichuan University and Zigong (2022CDZG-26) to HT.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterology. (2018) 154:302–18. doi: 10.1053/j.gastro.2017.07.049

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Cortés V, Amigo L, Zanlungo S, Galgani J, Robledo F, Arrese M, et al. Metabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice. PLoS ONE. (2015) 10:e0118478. doi: 10.1371/journal.pone.0118478

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Zhang Y, Liu H, Li L, Ai M, Gong Z, He Y, et al. Cholecystectomy can increase the risk of colorectal cancer: a meta-analysis of 10 cohort studies. PLoS ONE. (2017) 12:e0181852. doi: 10.1371/journal.pone.0181852

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Aurif F, Kaur H, Chio JPG, Kittaneh M, Malik BH. The association between cholecystectomy and colorectal cancer in the female gender. Cureus. (2021) 13:e20113. doi: 10.7759/cureus.20113

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Khalili M, Daniels L, Gleeson EM, Grandhi N, Thandoni A, Burg F, et al. Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: a systematic review. Surgery. (2019) 166:223–29. doi: 10.1016/j.surg.2019.04.020

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Paquette IM, Swenson BR, Kwaan MR, Mellgren AF, Madoff RD. Thirty-day outcomes in patients treated with en bloc colectomy and pancreatectomy for locally advanced carcinoma of the colon. J Gastrointest Surg. (2012) 16:581–6. doi: 10.1007/s11605-011-1691-7

PubMed Abstract | CrossRef Full Text | Google Scholar

7. van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, et al. The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update. J Crohns Colitis. (2020). doi: 10.1093/ecco-jcc/jjaa161. [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Jang JW, Lee SS, Song TJ, Hyun YS, Park DY, Seo DW, et al. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. (2012) 142:805–11. doi: 10.1053/j.gastro.2011.12.051

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. (2018) 15:11–20. doi: 10.1038/nrgastro.2017.109

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. (2011) 140:124–31. doi: 10.1053/j.gastro.2010.09.038

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Li D, Guo G, Xia L, Yang X, Zhang B, Liu F, et al. Relative handgrip strength is inversely associated with metabolic profile and metabolic disease in the general population in China. Front Physiol. (2018) 9:59. doi: 10.3389/fphys.2018.00059

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Hernaez R, Solà E, Moreau R, Ginès P. Acute-on-chronic liver failure: an update. Gut. (2017) 66:541–53. doi: 10.1136/gutjnl-2016-312670

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: gastroenterology, hepatology, pancreatobiliary disease, gastrointestinal tumor, reviews, non-alcoholic fatty liver disease, acute-on-chronic liver failure

Citation: Lan T, Druliner BR, Kostallari E and Tong H (2023) Editorial: Reviews in gastroenterology. Front. Med. 10:1200204. doi: 10.3389/fmed.2023.1200204

Received: 04 April 2023; Accepted: 11 April 2023;
Published: 28 April 2023.

Edited and reviewed by: Angel Lanas, University of Zaragoza, Spain

Copyright © 2023 Lan, Druliner, Kostallari and Tong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Enis Kostallari, kostallari.enis@mayo.edu; Huan Tong, doctortonghuan@163.com

These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.